---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-031345"
form_type: "8-K"
ticker: null
cik: "0001604477"
company_name: "SQZ Biotechnologies Co"
filed_at: "2023-07-03T23:59:59+00:00"
generated_at: "2026-06-13T13:17:11.918742+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# SQZ Biotechnologies receives NYSE delisting notice; reverse split deferred

## Summary
- NYSE notified SQZ on July 3 of delisting for average global market cap below $15M over 30 trading days.
- Company will not appeal; trading suspended after July 3 close. Stock begins OTC trading on July 5.
- OTC markets may offer less liquidity and could further depress stock price; no assurance of continued trading.
- Reverse stock split, previously set for July 6, deferred to an undetermined later date.

## SEC filing metadata
- accession: 0000950170-23-031345
- form_type: 8-K
- cik: 0001604477
- company_name: SQZ Biotechnologies Co
- filed_at: 2023-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604477/000095017023031345/0000950170-23-031345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604477/000095017023031345/sqz-20230703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-031345
- JSON: https://secwatch.observer/filing/0000950170-23-031345.json
- Plain text: https://secwatch.observer/filing/0000950170-23-031345.txt

## Key facts
- Listing & Compliance Notices
  SQZ Biotechnologies Co received a nyse delisting notice notice regarding market value (rules 802.01B).
  - Exchange: nyse
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 802.01B
  source text: July 3, 2023, SQZ Biotechnologies Company (the “Company”) received a written notice from the New York Stock Exchange (“NYSE”) notifying the Company that the NYSE will commence proceedings to delist the Company’s common stock (“Common Stock”) from the NYSE. The NYSE reached this determination pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization of at least $15 million over a consecutive 30-trading day period. The NYSE will apply to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604477/000095017023031345/0000950170-23-031345-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.